Comparison

CDD3505 European Partner

Item no. TMO-T13600-200mg
Manufacturer TargetMol
CASRN 173865-33-3
Amount 200 mg
Quantity options 100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mg 200 mg 25 mg 2 mg 500 mg 50 mg 5 mg
Category
Type Chemicals
Specific against other
Formula C22H17N3O2
Smiles [O-][N+](=O)c1cn(cn1)C(c1ccccc1)(c1ccccc1)c1ccccc1
ECLASS 10.1 32160000
ECLASS 11.0 32160000
UNSPSC 12000000
Alias 4-nitro-1-trityl-1H-imidazole
Shipping Condition Cool pack
Available
Manufacturer - Targets
Cytochromes P450
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
355.39
Description
CDD3505 (4-nitro-1-trityl-1H-imidazole) increases high-density lipoprotein cholesterol by targeting hepatic CYP3A.
Pathways
Metabolism
Bioactivity
CDD3505 is used for elevating high-density lipoprotein cholesterol (HDL) by inducing hepatic CYP3A activity.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 200 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close